Diabetes mellitus in pancreatic cancer and the need for diagnosis of asymptomatic disease

Pancreatology

Volumn 10, Issue 4, 2010, Pages 423-428

  Bartosch Harlid A ^a   Andersson, R ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Artificial neural networks; Diabetes mellitus; Pancreatic cancer; Peripheral insulin resistance

Indexed keywords

ARTIFICIAL NEURAL NETWORK; CANCER RISK; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; ENDOSCOPIC ECHOGRAPHY; GLUCOSE METABOLISM; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INFLAMMATION; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS CANCER; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW;

EID: 77955592753     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000264676     Document Type: Article

References (36)

1. Jemal A, Murray T, Ward E, Samuels A, Ti-wari RC, Ghafoor A, Feuer EJ, Thun MJ: Cancer statistics. CA Cancer J Clin 2005; 55: 10-30.
2. Carpelan-Holmström M, Nordling S, Puk-kala E, Sankila R, Lüttges J, Klöppel G, Ha-glund C: Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 2005; 54:385-387.
3. Shimizu Y, Yasui K, Matsueda K, Yanagisawa A, Yamao K: Small carcinoma of the pancreas is curable: new computed tomography finding, pathological study and postoperative results from a single institute. J Gastro-enterol Hepatol 2005; 20:1591-1594.
4. Permert J, Adrian TE, Jacobsson P, Jorfelt L, Fruin AB, Larsson J: Is profound peripheral insulin resistance in patients with PaC caused by a tumor-associated factor? Am J Surg 1993a;165: 61-67.
5. Everhart J, Wright D: DM as a risk factor for PaC: a meta-analysis. JAMA 1995; 273: 16 0 5-1609.
6. Chari ST, Leibson CL, Rabe KG, Timmons LJ, Ransom J, De Andrade M, Petersen GM: Pancreatic cancer-associated diabetes melli-tus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 2008; 134: 95-101.
7. Pannala R, Basu A, Petersen GM, Chari ST: New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 2009; 10:88-95.
8. Lowenfels AB, Maisonneuve P: Risk factors for pancreatic cancer. J Cell Biochem 2005; 95: 649-656.
9. Huxley R, Ansary-Moghaddam A, Ber-rington de Gonzaléz A, Barzi F, Woodward M: Type-II diabetes and PaC: a meta-analy-sis of 36 studies. 2005; 92:2076-2083.
10. Larsson SC, Orsini N, Wolk A: Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies. Int J Cancer 2007; 120: 1993-1998 . (Pubitemid 46418379)
11. Gullo L, Pezzilli R, Morselli-Labate AM; for Italian Pancreatic Cancer Study Group: diabetes and the risk of pancreatic cancer. N Engl J Med 1994; 331: 81-84 .
12. Wang F, Larsson J, Adrian TE: In vitro influences between pancreatic adenocarcinoma cel ls and pa ncreatic islets. J Sur Res 1998; 79: 13-19.
13. Suzuki H, Li Y, Dong X, Hassan MM, Ab-bruzzese JL, Li D: Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer. Cancer Epidemiol Bio-markers 2008; 17: 3467-3473.
14. Michaud DS, Wolpin B, Giovannucci E, Liu S, Cochrane B, Manson JAE, Pollak MN, Ma J, Fuchs CS: Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 2007; 16:2101-2109.
15. Schneider MB, Matsuzaki H, Haorah J, Ul-rich A , Sta ndop J, Di ng X-Z , Ad r ia n TE , Pour PM: Prevention of PaC induction in hamsters by metformin. Gastroenterology 2001; 120:1263-1270.
16. Perrin MC, Terry MB, Kleinhaus K, Deutsch L , Ya netz R, Ti ram E , Ca lderon R , Fried la nd-e r Y, Pa lt iel O, H a rl ap S : G e stat iona l d i abetes as a risk factor for pancreatic cancer: a prospective cohort study. BMC Med 2007; 5:25-31.
17. Liu J, Knezetic JA, Strömmer L, Permert J, Larsson J, Adrian TE: The intracellular mechanism of insulin resistance in pancreatic cancer patients. J Clin End Met 2000; 85: 1232-1238.
18. Permert J, Ihse I, Jorfeldt L, von Schenck H, Arnqvist HJ, Larsson J: Improved glucose metabolism after subtotal pancreatectomy for PaC. Br J Surg 1993; 80:1047-1050.
19. Chari ST, Zapiach M, Yadav D, Rizza RA: Beta-cell function and insulin resistance evaluated by HOMA in pancreatic cancer subjects with varying degrees of glucose intolerance. Pancreatology 2005; 5:229-233.
20. Leighton B, Cooper GJ: Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 1998; 335:632-635.
21. Katsumichi I, Pour PM: Diabetes mellitus in pancreatic cancer: is it a causal relationship? Am J Sur 2007; 194: 71-75.
22. Basso D, Millino C, Greco E, Romualdi C, Fogar P, Valerio A, Bellin M, Zambon CF, Navaglia F, Dussini N, Avogaro A, Pedraz-zol i S, La nfranchi G, Plebani M: Altered glucose metabolism and proteolysis in PaC cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5,000 skeletal muscle genes. Gut 2004; 53: 1159-116 6 .
23. Ding X, Flatt PR, Permert J, Adrian TE: Pancreatic cancer cells selectively stimulate islet beta cells to secrete amylin. Gastroenterolo-gy 1998; 114 : 130-138.
24. Tingstedt B, Johansson P, Andersson B, An-dersson R: Predictive factors in pancreatic ductal adenocarcinoma: role of the inflammatory response. Scand J Gastroenterol 2007; 42:754-759.
25. Ebrahimi B, Tucker SL, Li D, Abbruzzese JL, Kurzrock R: Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer 2004; 101: 2727-2736.
26. Martignoni ME, Kunze P, Hildebrandt W, Künzli B, Berberat P, Giese T, Klöters O, Hammer J, Büchler MW, Giese NA, Friess H: Role of mononuclear cells and inf lammatory cytokines in PaC-related cachexia. Clin Cancer Res 2005; 11 : 5802-5808.
27. Bodner WR, Hilaris BS, Mastoras DA: Radiation therapy in pancreatic cancer: current practice and future trends. J Clin Gastroen-terol 2000; 30: 230-233.
28. Klein AP, Brune KA, Petersen GM, Goggins M, Tersmette AC, Offerhaus GJ, Griffin C, Cameron JL, Yeo CJ, Kern S, Hruban RH: Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 2004; 64:2634-2638. (Pubitemid 38523922)
29. Haykin S: Neural Networks: A Compressive Foundation, ed 2. Upper Saddle River, Prentice-Hall, 1999.
30. Stephan C, Cammann H, Meyer HA, Lein M, Jung K: PSA and new biomarkers within multivariate models to improve early detection of prostate cancer. Cancer Lett 2007; 249:18-29.
31. Norton ID, Zheng Y, Wiersema MS, Green-leaf J, Clain JE, Dimagno EP: Neural network analysis of EUS images to differentiate between pancreatic malignancy and pancreatitis. Gastrointest Endosc 2001; 54: 625-629.
32. Iked a M, Ito S, Ishiga k i T, Ya mauch i K: Eva l-uation of a neural network classifier for pancreatic masses based on CT findings. Com-put Med Imaging Graph 1997; 21:175-183.
33. Mattfeldt T, Gottfried H, Schmidt V, Kestler HA: Classification of spatial textures in benign and cancerous glandular tissues by ste-reology and stochastic geometry using arti-ficia l neural networks. J Microsc 200 0; 198: 14 3-158.
34. Honda K, Hayashida Y, Umaki T, Okusaka T, Kosuge T, Kikuchi S, Endo M, Tsuchida A, Aoki T, Itoi T, Moriyasu F, Hirohashi S, Yamada T: Possible detection of pancreatic cancer by plasma protein profiling. Cancer Res 2005; 65: 10 613-10 622 .
35. Okon K, Tomaszewska R, Nowak K, Stachu-ra J: Application of neural networks to the classification of pancreatic intraductal pro-liferative lesions. Anal Cell Pathol 2001; 23: 129-136.
36. Sftoiu A, Vilmann P, Gorunescu F, Gheo-nea DI, Gorunescu M, Ciurea T, Popescu GL, Iordache A, Hassan H, Iordache S: Neural network analysis of dynamic sequences of EUS elastography used for the differential diagnosis of chronic pancreatitis and pancreatic cancer. Gastrointest Endosc 2008; 68: 1086-1094.